PLK4 and neuroblastoma: The Chr17q region containing the centrosomal ubiquitin ligase TRIM37 gene has recently been shown to be frequently amplified in neuroblastoma and breast cancer, rendering these cancer types highly sensitive to Serine/Threonine Protein kinase PLK4 (Polo-like Kinase 4) inhibition [37].